author-photo

Pietro Sodani

Sapienza University of Rome

44

Papers

1081

Citations

Citation Trend

Filter By

Papers (31) Sort By

Journal Conference Others

Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis

2020 Respiratory medicine case reports
Show All
- Source
- Cite
- Save
Citations (2)
One single bone marrow harvesting from donors under 3 years of age: assessing safety and efficacy of the procedure

2018 Bone Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (1)
Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ+/CD19+-depleted grafts

2018 Blood Advances
Show All
- Source
- Cite
- Save
Citations (46)
Impact of Donor-Specific anti-HLA antibodies and donor KIR characteristics in haploidentical HSCT for beta-Thalassemia

2017 Mediterranean Journal of Hematology and Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (3)
Long-Term Outcome after Haploidentical Hematopoietic Cell Transplantation Utilizing CD34+ Selected/CD3CD19+ Depleted or Tcrαβ+/CD19+ Depleted Grafts in Pediatric Patients with Hemoglobinopathies

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Optimal Outcomes in Young Class 3 Patients With Thalassemia Undergoing HLA-Identical Sibling Bone Marrow Transplantation

2016 Transplantation
Show All
- Source
- Cite
- Save
Citations (29)
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β 0 -Thalassemia Families with High Fetal Hemoglobin Levels

2016 Molecular Diagnosis & Therapy
Show All
- Source
- Cite
- Save
Citations (13)
New insights into the pharmacokinetics of intravenous busulfan in children with sickle cell anemia undergoing bone marrow transplantation

2015 Pediatric Blood & Cancer
Show All
- Source
- Cite
- Save
Citations (10)
Hematopoietic Stem Cell Transplantation in Nigerian Children with Sickle Cell Anemia

2015 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Transplant Outcomes in High-Risk (Class 3) Patients with Thalassemia Treated with a Modified Protocol Are Equivalent to Low/Intermediate-Risk (Class 1/Class 2) Patients

2015 Blood
Show All
- Source
- Cite
- Save
Citations (4)